Paper38239352
MediMer: a versatile do-it-yourself peptide-receptive MHC class I multimer platform for tumor neoantigen-specific T cell detection.
Meyer M and 24 others. Front Immunol, 2023. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. MediMer: a versatile do-it-yourself peptide-receptive MHC class I multimer platform for tumor neoantigen-specific T cell detection. Papers, record 38239352. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38239352
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- MediMer: a versatile do-it-yourself peptide-receptive MHC class I multimer platform for tumor neoantigen-specific T cell detection.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| CD8-Positive T-Lymphocytes | Major topic |
| Peptides | Major topic |
| Humans | |
| Receptors, Antigen, T-Cell | |
| HLA Antigens | |
| Antigens, Neoplasm |
Source PubMed
References90
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20087680 | Overview of a HLA-Ig based "Lego-like system" for T cell monitoring, modulation and expansion. | Immunol Res | 2010 | https://conductscience.org/library/papers/20087680 | PubMed |
| 2 | 17406393 | Generation of peptide-MHC class I complexes through UV-mediated ligand exchange. | Nat Protoc | 2006 | https://conductscience.org/library/papers/17406393 | PubMed |
| 3 | 16462803 | Design and use of conditional MHC class I ligands. | Nat Med | 2006 | https://conductscience.org/library/papers/16462803 | PubMed |
| 4 | 12445736 | Peptide-beta2-microglobulin-MHC fusion molecules bind antigen-specific T cells and can be used for multivalent MHC-Ig complexes. | J Immunol Methods | 2002 | https://conductscience.org/library/papers/12445736 | PubMed |
| 5 | 27787794 | pMHC Multiplexing Strategy to Detect High Numbers of T Cell Responses in Parallel. | Methods Mol Biol | 2017 | https://conductscience.org/library/papers/27787794 | PubMed |
| 6 | 21795600 | TCRs used in cancer gene therapy cross-react with MART-1/Melan-A tumor antigens via distinct mechanisms. | J Immunol | 2011 | https://conductscience.org/library/papers/21795600 | PubMed |
| 7 | 33853928 | SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8+ T cell activation in COVID-19 patients. | Sci Immunol | 2021 | https://conductscience.org/library/papers/33853928 | PubMed |
| 8 | 31324691 | High-throughput peptide-MHC complex generation and kinetic screenings of TCRs with peptide-receptive HLA-A*02:01 molecules. | Sci Immunol | 2019 | https://conductscience.org/library/papers/31324691 | PubMed |
| 9 | 19543285 | Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers. | Nat Methods | 2009 | https://conductscience.org/library/papers/19543285 | PubMed |
| 10 | 20212098 | Single-chain HLA-A2 MHC trimers that incorporate an immundominant peptide elicit protective T cell immunity against lethal West Nile virus infection. | J Immunol | 2010 | https://conductscience.org/library/papers/20212098 | PubMed |
| 11 | 2199065 | Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro. | Cell | 1990 | https://conductscience.org/library/papers/2199065 | PubMed |
| 12 | 17719490 | Structural engineering of pMHC reagents for T cell vaccines and diagnostics. | Chem Biol | 2007 | https://conductscience.org/library/papers/17719490 | PubMed |
| 13 | 18366814 | Precision and linearity targets for validation of an IFNgamma ELISPOT, cytokine flow cytometry, and tetramer assay using CMV peptides. | BMC Immunol | 2008 | https://conductscience.org/library/papers/18366814 | PubMed |
| 14 | 1999227 | A single-chain murine class I major transplantation antigen. | Eur J Immunol | 1991 | https://conductscience.org/library/papers/1999227 | PubMed |
| 15 | 36890230 | Neoantigen-targeted CD8+ T cell responses with PD-1 blockade therapy. | Nature | 2023 | https://conductscience.org/library/papers/36890230 | PubMed |
| 16 | 30683863 | Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patients. | Nat Commun | 2019 | https://conductscience.org/library/papers/30683863 | PubMed |
| 17 | 11592075 | Efficient assembly of recombinant major histocompatibility complex class I molecules with preformed disulfide bonds. | Eur J Immunol | 2001 | https://conductscience.org/library/papers/11592075 | PubMed |
| 18 | 30465909 | A novel and simple method to produce large amounts of recombinant soluble peptide/major histocompatibility complex monomers for analysis of antigen-specific human T cell receptors. | N Biotechnol | 2019 | https://conductscience.org/library/papers/30465909 | PubMed |
| 19 | 15800656 | Cancer immunotherapy using a DNA vaccine encoding a single-chain trimer of MHC class I linked to an HPV-16 E6 immunodominant CTL epitope. | Gene Ther | 2005 | https://conductscience.org/library/papers/15800656 | PubMed |
| 20 | 29242379 | High-throughput and Sensitive Immunopeptidomics Platform Reveals Profound Interferonγ-Mediated Remodeling of the Human Leukocyte Antigen (HLA) Ligandome. | Mol Cell Proteomics | 2018 | https://conductscience.org/library/papers/29242379 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42738839 | T-Cell Receptor Single-Chain Antibody IgG1-Fc Fusion Proteins as Bispecific Engagers for Natural Killer and T Cells. | Cells | 2026 | https://conductscience.org/library/papers/42738839 | PubMed |
| 40671675 | Neo-antigen tumor vaccination depends on CD4-licensing conveyed by adeno-associated virus like particles. | Mol Ther | 2025 | https://conductscience.org/library/papers/40671675 | PubMed |
| 39902862 | Isolation of a tumor neoantigen specific CD8+ TCR from a skin biopsy of a vaccination site. | Oncoimmunology | 2025 | https://conductscience.org/library/papers/39902862 | PubMed |
| 39623867 | Probing TCR Specificity Using Artificial In Vivo Diversification of CDR3 Regions. | Eur J Immunol | 2025 | https://conductscience.org/library/papers/39623867 | PubMed |
| 38803176 | The Future of TCR-like Antibodies in Diagnosis and Potential Application Targets. | Curr Mol Med | 2025 | https://conductscience.org/library/papers/38803176 | PubMed |
Genes30
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38239352
GET https://conductscience.org/api/papers/v1/38239352/authors?page=2